相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。USP21 regulates Hippo signaling to promote radioresistance by deubiquitinating FOXM1 in cervical cancer
Zhengliang Li et al.
HUMAN CELL (2022)
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma
Leticia Colyn et al.
HEPATOLOGY (2021)
Epigenetic Modifier UHRF1 May Be a Potential Target in Malignant Pleural Mesothelioma
Anne-Marie Baird et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Small-cell lung cancer
Charles M. Rudin et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Prognostic significance of epigenetic regulatory gene expression in patients with non-small-cell lung cancer
Zegui Tu et al.
Aging-US (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies
Camille Tlemsani et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP/TAZ
Giulia Della Chiara et al.
NATURE COMMUNICATIONS (2021)
Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer
Xiaoya Zhao et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
The multi-functionality of UHRF1: epigenome maintenance and preservation of genome integrity
Monica Mancini et al.
NUCLEIC ACIDS RESEARCH (2021)
USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer
Beiqing Pan et al.
PROTEIN & CELL (2020)
YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma
Hirofumi Omori et al.
SCIENCE ADVANCES (2020)
Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine
Anwesha Dey et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Targeting UHRF1-dependent DNA repair selectively sensitizes KRAS mutant lung cancer to chemotherapy
Danmei Tian et al.
CANCER LETTERS (2020)
Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma
Marina Barcena-Varela et al.
HEPATOLOGY (2019)
A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling
Xiao Zheng et al.
MOLECULAR CANCER (2019)
Usp7 regulates Hippo pathway through deubiquitinating the transcriptional coactivator Yorkie
Xiaohan Sun et al.
NATURE COMMUNICATIONS (2019)
Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties
Xiangqian Kong et al.
CANCER CELL (2019)
Current Diagnosis and Management of Small-Cell Lung Cancer
Shuhang Wang et al.
MAYO CLINIC PROCEEDINGS (2019)
Targeting DNA Replication Stress and DNA Double-Strand Break Repair for Optimizing SCLC Treatment
Xing Bian et al.
CANCERS (2019)
Methylation of UHRF1 by SET7 is essential for DNA double-strand break repair
Ja Young Hahm et al.
NUCLEIC ACIDS RESEARCH (2019)
PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells
Linglong Yin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
UHRF1 depletion sensitizes retinoblastoma cells to chemotherapeutic drugs via downregulation of XRCC4
Heng He et al.
CELL DEATH & DISEASE (2018)
FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness
Bowen Yuan et al.
CELL DEATH & DISEASE (2018)
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
L. Horn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Replication fork stability confers chemoresistance in BRCA-deficient cells
Arnab Ray Chaudhuri et al.
NATURE (2016)
Small cell lung cancer: Time to revisit DNA-damaging chemotherapy
Anish Thomas et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
A cell cycle-dependent BRCA1-UHRF1 cascade regulates DNA double-strand break repair pathway choice
Haoxing Zhang et al.
NATURE COMMUNICATIONS (2016)
An Allosteric Interaction Links USP7 to Deubiquitination and Chromatin Targeting of UHRF1
Zhi-Min Zhang et al.
CELL REPORTS (2015)
UHRF1 Contributes to DNA Damage Repair as a Lesion Recognition Factor and Nuclease Scaffold
Yanyan Tian et al.
CELL REPORTS (2015)
UHRF1 Overexpression Drives DNA Hypomethylation and Hepatocellular Carcinoma
Raksha Mudbhary et al.
CANCER CELL (2014)
Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers
Sophie Rousseaux et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer
Teruyuki Sato et al.
SCIENTIFIC REPORTS (2013)
Yes-Associated Protein 1 Is Activated and Functions as an Oncogene in Meningiomas
Gilson S. Baia et al.
MOLECULAR CANCER RESEARCH (2012)
Expression of G Protein-Coupled Receptor 19 in Human Lung Cancer Cells Is Triggered by Entry into S-Phase and Supports G2-M Cell-Cycle Progression
Stefan Kastner et al.
MOLECULAR CANCER RESEARCH (2012)
ASCL1-coexpression profiling but not single gene expression profiling defines lung adenocarcinomas of neuroendocrine nature with poor prognosis
Takeshi Fujiwara et al.
LUNG CANCER (2012)
Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1
Lauren Averett Byers et al.
CANCER DISCOVERY (2012)
UHRF1 is a novel diagnostic marker of lung cancer
M. Unoki et al.
BRITISH JOURNAL OF CANCER (2010)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Targeted disruption of Np95 gene renders murine embryonic stem cells hypersensitive to DNA damaging agents and DNA replication blocks.
M Muto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
